Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

2006/03/01 by Richard J. Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck +5 · 2 citations

paper · doi:10.1016/j.eururo.2005.12.031

Cited by

• Large multicenter validation of urine RNA profile for urothelial carcinoma detection and surveillance
• AI-Based Clinical Rule Discovery for NMIBC Recurrence through Tsetlin Machines